• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.依那西普治疗使一名类风湿关节炎患者成功清除丙型肝炎病毒。
Gastroenterol Hepatol (N Y). 2011 Nov;7(11):772-4.
2
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.在一名接受依那西普治疗的银屑病关节炎、合并乙型肝炎病毒感染及潜伏性结核患者中，聚乙二醇化干扰素α-2a联合利巴韦林成功清除丙型肝炎病毒。
Ann Rheum Dis. 2011 Jul;70(7):1343-4. doi: 10.1136/ard.2010.139824. Epub 2010 Dec 3.
3
Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.类风湿关节炎患者同时使用甲氨蝶呤时依那西普的药代动力学未改变。
J Clin Pharmacol. 2004 Nov;44(11):1235-43. doi: 10.1177/0091270004268049.
4
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.依那西普治疗银屑病关节炎合并丙型肝炎病毒感染患者：3例报告
J Am Acad Dermatol. 2004 Oct;51(4):580-4. doi: 10.1016/j.jaad.2004.05.013.
5
Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review.使用依那西普治疗一名HIV阳性患者的类风湿性关节炎：基于病例的综述。
Rheumatol Int. 2017 Jul;37(7):1207-1212. doi: 10.1007/s00296-017-3690-9. Epub 2017 Mar 2.
6
Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients.肿瘤坏死因子-α（TNF-α）拮抗剂英夫利昔单抗、依那西普和阿达木单抗在合并类风湿性关节炎和乙型或丙型肝炎患者中的应用：11例患者的回顾性记录分析
Clin Rheumatol. 2009 Jul;28(7):787-91. doi: 10.1007/s10067-009-1149-4. Epub 2009 Mar 17.
7
Effect of etanercept and entecavil in a patient with rheumatoid arthritis who is a hepatitis B carrier: a review of the literature.乙型肝炎携带者类风湿关节炎患者使用依那西普和恩他卡韦治疗的效果：文献复习。
Rheumatol Int. 2012 Apr;32(4):1059-63. doi: 10.1007/s00296-009-1344-2. Epub 2010 Jan 9.
8
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.类风湿关节炎合并丙型肝炎病毒感染患者使用依那西普和甲氨蝶呤的安全性：一项多中心随机临床试验。
J Rheumatol. 2014 Feb;41(2):286-92. doi: 10.3899/jrheum.130658. Epub 2014 Jan 15.
9
A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis.1例类风湿关节炎患者使用依那西普后加重自身免疫性肝炎的病例。
Clin Rheumatol. 2008 Aug;27(8):1063-6. doi: 10.1007/s10067-008-0885-1. Epub 2008 Jun 18.
10
Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement.利用血清药物水平和抗药物抗体测量预测类风湿关节炎患者阿达木单抗、依那西普或英夫利昔单抗成功减药或停药。
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):597-604. doi: 10.1080/17425255.2017.1320390. Epub 2017 Apr 24.

引用本文的文献

1
Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics.基孔肯雅病毒感染人巨噬细胞的时间过程揭示了与重新定位治疗药物相关的细胞内信号通路。
PeerJ. 2022 Mar 21;10:e13090. doi: 10.7717/peerj.13090. eCollection 2022.
2
Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.接受免疫抑制药物治疗的丙型肝炎患者的治疗
J Clin Transl Hepatol. 2016 Sep 28;4(3):206-227. doi: 10.14218/JCTH.2016.00017. Epub 2016 Aug 10.
3
Etanercept attenuates myocardial ischemia/reperfusion injury by decreasing inflammation and oxidative stress.依那西普通过减轻炎症和氧化应激来减轻心肌缺血/再灌注损伤。
PLoS One. 2014 Sep 26;9(9):e108024. doi: 10.1371/journal.pone.0108024. eCollection 2014.
4
Hepatitis C virus treatment complicated by rheumatoid arthritis.丙型肝炎病毒治疗并发类风湿关节炎。
Gastroenterol Hepatol (N Y). 2011 Nov;7(11):774-6.

本文引用的文献

1
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.通过肝脏组织病理学评估依那西普在银屑病合并丙型肝炎病毒患者中的安全性：初步数据。
J Am Acad Dermatol. 2010 Jun;62(6):1067-9. doi: 10.1016/j.jaad.2009.07.010.
2
Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis.依那西普治疗可降低类风湿关节炎患者血清中白细胞介素-15 和干扰素-γ诱导蛋白-10 的水平。
Rheumatol Int. 2010 Apr;30(6):725-30. doi: 10.1007/s00296-009-1356-y. Epub 2010 Jan 10.
3
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.依那西普作为干扰素-α和利巴韦林治疗活动期丙型肝炎感染前的预防性银屑病治疗药物。
Clin Exp Dermatol. 2010 Jun;35(4):397-8. doi: 10.1111/j.1365-2230.2009.03476.x. Epub 2009 Jul 29.
4
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection.类风湿关节炎合并慢性丙型肝炎病毒感染患者使用抗肿瘤坏死因子-α治疗的安全性
J Rheumatol. 2008 Oct;35(10):1944-9. Epub 2008 Aug 1.
5
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.干扰素（IFN）-γ诱导蛋白10：与聚乙二醇化干扰素α-2a联合利巴韦林治疗慢性丙型肝炎病毒感染期间的组织学结果、病毒动力学及疗效的相关性
J Infect Dis. 2006 Oct 1;194(7):895-903. doi: 10.1086/507307. Epub 2006 Aug 29.
6
Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.1型慢性丙型肝炎感染患者治疗前血清干扰素γ诱导蛋白10水平与聚乙二醇干扰素联合利巴韦林治疗持续病毒学应答的相关性
Gut. 2006 Mar;55(3):374-9. doi: 10.1136/gut.2005.074062. Epub 2005 Sep 8.
7
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study.依那西普作为初治慢性丙型肝炎病毒感染患者干扰素和利巴韦林治疗的辅助药物：一项2期随机、双盲、安慰剂对照研究。
J Hepatol. 2005 Mar;42(3):315-22. doi: 10.1016/j.jhep.2004.11.025.
8
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.类风湿关节炎患者经可溶性肿瘤坏死因子α受体治疗后外周血T细胞对微生物抗原和II型胶原反应性增强。
Ann Rheum Dis. 2001 Feb;60(2):133-9. doi: 10.1136/ard.60.2.133.
9
Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis.用单克隆抗肿瘤坏死因子α抗体治疗会导致类风湿性关节炎患者外周血中Th1 CD4 + T细胞积聚。
Arthritis Rheum. 1999 Oct;42(10):2166-73. doi: 10.1002/1529-0131(199910)42:10<2166::AID-ANR18>3.0.CO;2-K.
10
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.慢性丙型肝炎病毒（HCV）感染患者中肿瘤坏死因子（TNF）p55型和p75型受体的诱导情况。
Clin Exp Immunol. 1998 Feb;111(2):269-77. doi: 10.1046/j.1365-2249.1998.00469.x.

Etanercept treatment to enable successful hepatitis C virus clearance in a patient with rheumatoid arthritis.

作者信息

Jazwinski Alison B, Jezsik Janet, Ardoin Stacy P, McCallum Rex M, Tillmann Hans L

机构信息

Division of Gastroenterology and Hepatology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Gastroenterol Hepatol (N Y). 2011 Nov;7(11):772-4.

PMID:22298976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3264933/
Abstract
摘要